As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Pharvaris N.V. The largest reported stake is General Atlantic, L.P.'s, at 7.6%. 6 filings are on record since August 14, 2025 (Schedule 13G/A, August 14, 2026).
Sell to companies like Pharvaris N.V? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: General Atlantic, L.P. · Sole voting: 0 · Shared voting: 5,359,727 · Sole dispositive: 0 · Shared dispositive: 5,359,727 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: LSP V Cooperatieve U.A. · Sole voting: 0 · Shared voting: 3,424,609 · Sole dispositive: 0 · Shared dispositive: 3,424,609 · SCHEDULE 13G/A, 2026-07-31
- · Reporting person: Viking Global Investors LP · Sole voting: 0 · Shared voting: 3,653,310 · Sole dispositive: 0 · Shared dispositive: 3,653,310 · SCHEDULE 13G/A, 2026-05-15
- · Holder: Bain Capital Life Sciences Fund, L.P. · Percent: 2.5% · SCHEDULE 13G/A
- · Holder: Bain Capital Life Sciences Fund, L.P. · Percent: 3% · SCHEDULE 13G/A
Pharvaris N.V. has 6 Schedule 13D or 13G filings on record since 2025-08-14. 2 holders' latest filing reports 5% or more of ordinary shares, par value euro 0.12 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| General Atlantic, L.P. | 7.6% | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Viking Global Investors LP | 5.6% | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| 4.9% | 3,424,609 | SCHEDULE 13G/A, 2026-07-31 | 2026-06-30 | |
| Venrock Healthcare Capital Partners III, L.P. | 3.8% | 2,047,620 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| Bain Capital Life Sciences Fund, L.P. | 2.5% | 1,640,817 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
Holding shares or following this stake? See who's behind Pharvaris N.V. and the warning signs.
Free to see. No signup.
Keep reading
More on Pharvaris N.V. and the records around it.
Pharvaris N.V. elsewhere on the record
Companies that share a holder
- Bain Capital Life Sciences Fund, L.P. also filed stake reports on 2 other companies: Rapid Micro Biosystems, Inc. (Aug 2026), X4 PHARMACEUTICALS, INC. (Feb 2026)
- GENERAL ATLANTIC, L.P. also filed stake reports on 10 other companies: Korsana Biosciences, Inc. (Sep 2026), dLocal Ltd (Aug 2026), Liftoff Mobile, Inc. (Jun 2026)
- VIKING GLOBAL INVESTORS LP also filed stake reports on 27 other companies: City Therapeutics, Inc. (Oct 2026), MID AMERICA APARTMENT COMMUNITIES INC. (Oct 2026), REGAL REXNORD CORP (Sep 2026)
Watch Pharvaris N.V.
Get an email when Pharvaris N.V. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Pharvaris N.V.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Pharvaris N.V.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pharvaris N.V. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| General Atlantic, L.P. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic PH B.V. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic Cooperatief U.A. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic Partners (Bermuda) IV, L.P. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic Partners (Bermuda) EU, L.P. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic Partners (Lux) SCSp | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic Cooperatief, L.P. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| GAP Coinvestments III, LLC | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| GAP Coinvestments IV, LLC | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| GAP Coinvestments V, LLC | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| GAP Coinvestments CDA, L.P. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic GenPar (Lux) SCSp | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic (Lux) S.a r.l. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| General Atlantic GenPar (Bermuda), L.P. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| GAP (Bermuda) L.P. | 0 | 5,359,727 | 0 | 5,359,727 | SCHEDULE 13G/A, 2026-08-14 |
| Viking Global Investors LP | 0 | 3,653,310 | 0 | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 |
| Viking Global Opportunities Parent GP LLC | 0 | 3,653,310 | 0 | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 |
| Viking Global Opportunities GP LLC | 0 | 3,653,310 | 0 | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 |
| Viking Global Opportunities Portfolio GP LLC | 0 | 3,653,310 | 0 | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 0 | 3,653,310 | 0 | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 |
| Halvorsen Ole Andreas | 0 | 3,653,310 | 0 | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 |
| Shabet Rose Sharon | 0 | 3,653,310 | 0 | 3,653,310 | SCHEDULE 13G/A, 2026-05-15 |
| LSP V Cooperatieve U.A. | 0 | 3,424,609 | 0 | 3,424,609 | SCHEDULE 13G/A, 2026-07-31 |
| LSP V Management B.V. | 0 | 3,424,609 | 0 | 3,424,609 | SCHEDULE 13G/A, 2026-07-31 |
The latest filing identifies Pharvaris N.V. by CUSIP N69605108 and gives its principal executive office as Emmy Noetherweg 2, Leiden (SCHEDULE 13G/A, 2026-08-14).
What the percentages are based on
All calculations of percentage ownership herein are based on 70,204,506 ordinary shares reported by the Company to be outstanding as of June 30, 2026, as reported by the Company in its Unaudited Condensed Consolidated Interim Financial Statements as of and for the three and six months ended June 30, 2026 and 2025 and as of December 31, 2025, filed with the U.S.General Atlantic, L.P., SCHEDULE 13G/A, 2026-08-14
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Venrock Healthcare Capital Partners III, L.P. | 3.8% | SCHEDULE 13G/A |
| 2025-11-14 | Bain Capital Life Sciences Fund, L.P. | 3% | SCHEDULE 13G/A |
| 2026-02-17 | Bain Capital Life Sciences Fund, L.P. | 2.5% | SCHEDULE 13G/A |
| 2026-05-15 | Viking Global Investors LP | 5.6% | SCHEDULE 13G/A |
| 2026-07-31 | LSP V Cooperatieve U.A. | 4.9% | SCHEDULE 13G/A |
| 2026-08-14 | General Atlantic, L.P. | 7.6% | SCHEDULE 13G/A |
Questions about who owns Pharvaris N.V.
Who owns Pharvaris N.V.?
On this page, 2 holders' latest ownership filings report 5% or more of Pharvaris N.V.: General Atlantic, L.P. (7.6%, Schedule 13G/A, filed 2026-08-14) and Viking Global Investors LP (5.6%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of Pharvaris N.V.?
By the share each holder's latest filing reports, the largest holders of Pharvaris N.V. on this page are General Atlantic, L.P. (7.6%) and Viking Global Investors LP (5.6%).
When did General Atlantic, L.P. buy into Pharvaris N.V.?
The filings give report dates, not purchase dates. The earliest filing from General Atlantic, L.P. on this page is the Schedule 13G/A, filed 2026-08-14, reporting 7.6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Pharvaris N.V.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.